For the first time, a team of experts from the Technical University of Munich (TUM), RWTH Aachen University, and the German ...

Rates of multiple myeloma (MM), the second most common blood cancer in the United States, are increasing and are twice as ...

Changes in genes have been linked to the development of different diseases for a while. However, it's not exactly clear what ...

A team of Australian researchers have developed a new targeted therapeutic approach that could improve treatment for ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to Alessa Therapeutics for its lead product ...

The collaborative clinical study will evaluate ADSTILADRIN® (nadofaragene firadenovec-vncg) in combination with the investigational drug Ruvidar® (TLD-1433) in patients with Bacillus ...

The FDA-approved drug combination specifically targets low-grade serous ovarian cancer, which primarily affects younger women ...

Global cancer cases have surged dramatically, doubling since 1990 and reaching 18.5 million new diagnoses in 2023. Deaths ...

Cancer is a disease that starts with uncontrolled cell division and eventually causes tissue and organ damage. The disease ...

A recent study published in the medical journal Gut has revealed a novel cancer-promoting mechanism of Streptococcus ...

The decision to end the programme comes 18 months after Genmab's former partner for the acasunlimab, BioNTech, pulled out of ...

A new study by the National Cancer Research Centre (CNIO) has identified several sets of genes related to the predisposition ...